---
figid: PMC3589702__zlj9991029930002
figtitle: Targeting of the hepatocyte growth factor (HGF)/MET pathway
organisms:
- NA
pmcid: PMC3589702
filename: zlj9991029930002.jpg
figlink: /pmc/articles/PMC3589702/figure/F2/
number: F2
caption: Targeting of the hepatocyte growth factor (HGF)/MET pathway. HGF-dependent
  activation of the MET pathway can be disrupted through extracellular therapies that
  interfere with HGF binding to MET. Intracellular approaches can inhibit HGF-dependent
  and -independent mechanisms that lead to phosphorylation of MET kinase substrates.
papertitle: MET As a Possible Target for Nonâ€“Small-Cell Lung Cancer.
reftext: Ahad A. Sadiq, et al. J Clin Oncol. 2013 Mar 10;31(8):1089-1096.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9127836
figid_alias: PMC3589702__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC3589702__F2
ndex: 3e94546b-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3589702__zlj9991029930002.html
  '@type': Dataset
  description: Targeting of the hepatocyte growth factor (HGF)/MET pathway. HGF-dependent
    activation of the MET pathway can be disrupted through extracellular therapies
    that interfere with HGF binding to MET. Intracellular approaches can inhibit HGF-dependent
    and -independent mechanisms that lead to phosphorylation of MET kinase substrates.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sema1a
  - ATPsynbeta
  - Atpalpha
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Fak
  - dos
  - grb
  - Stat92E
  - ras
  - Ras64B
  - Ras85D
  - Sos
  - Erk7
  - rl
  - Dsor1
  - Mtk
  - Raf
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
